Sarver Vrooman Wealth Advisors Vericel Corp Transaction History
Sarver Vrooman Wealth Advisors
- $150 Billion
- Q1 2025
A detailed history of Sarver Vrooman Wealth Advisors transactions in Vericel Corp stock. As of the latest transaction made, Sarver Vrooman Wealth Advisors holds 1 shares of VCEL stock, worth $39. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$39% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$318 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$138 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$114 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$96 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$89.6 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.86B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...